Loading viewer...
investor_presentation
Format: PDF investor_presentation
Pulmatrix is a clinical-stage biopharmaceutical company developing inhalation-based therapeutics, with focus on PUR3100 and pipeline candidates PUR1900 and PUR1800. The presentation covers clinical data, market opportunity, and risk profile for their investigational drug programs.
investor_presentation
38 Pages
Superior Gold
Groupama Assurances Mutuelles RT1 Investor Presentation July 2024
investor_presentationinvestor_presentation
34 Pages
Groupama Assurances Mutuelles